Investment case
Twist Bioscience Corporation
TWST · 8 developments mapped · last assessed 2026-09-20
Market Ontology has mapped 8 macro, policy, and market developments to Twist Bioscience Corporation since 2026-09-19. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for TWST yet, so no modelled value is shown. The TWST valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run TWST on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Deal
Direct revenue generation from partnership, validation of technology, potential for future milestones/royalties.
· Moves revenue growth rate, profitability outlook, market share in synthetic biology/antibody discovery
What changed, by assumption
- 2026-09-20Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Deal
- 2026-09-19Twist Bioscience Partners with Eli Lilly on AI Drug Discovery Platform
- 2026-09-19Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platform
- 2026-09-19Twist Bioscience partners with Eli Lilly on TuneLab AI discovery
- 2026-09-20Twist Bioscience shares gain 31% on Eli Lilly AI drug discovery pact
- 2026-09-19Twist Bioscience partners with Eli Lilly on AI-driven TuneLab drug discovery
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-20 | Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Deal | Bullish | 1-3m | 0.90 |
| 2026-09-20 | Twist Bioscience shares gain 31% on Eli Lilly AI drug discovery pact | Bullish | 1-3m | 0.90 |
| 2026-09-19 | Twist Bioscience partners with Eli Lilly on TuneLab AI discovery | Bullish | 1-3m | 0.80 |
| 2026-09-19 | Twist Bioscience partners with Eli Lilly on AI-driven TuneLab drug discovery | Bullish | 1-3m | 0.80 |
| 2026-09-19 | Twist Bioscience Partners with Eli Lilly on AI Drug Discovery Platform | Bullish | 3-12m | 0.90 |
| 2026-09-19 | Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platform | Bullish | 1-3m | 0.90 |
| 2026-09-19 | Twist Bioscience Partners With Eli Lilly on TuneLab AI Drug Discovery | Bullish | 1-3m | 0.80 |
| 2026-09-19 | Twist Bioscience Rallies 31% on Eli Lilly AI Drug Discovery Collaboration | Bullish | 1-3m | 0.90 |